Taurine

Updated June 3, 2026

Heart muscle, retina, brain, white blood cells. These are the tissues where taurine sits at the highest concentrations in your body, and that distribution tells you a lot about what it actually does. The body makes some from cysteine and methionine. Synthesis falls short of demand more often than people realize, especially with age, illness, alcohol use, vegetarian diets, and certain medications. In 2023, Vijay Yadav's group at Columbia published a Science paper (Singh and colleagues) showing taurine levels drop substantially with aging across mice, monkeys, and humans, and that supplementing the substrate reversed several aging markers in the animal models. That paper put taurine on the longevity map for a generation that had been treating it as a throwaway ingredient in energy drinks. The biology underneath the headline is older than the headline.

A small technical point worth noting. Taurine is not really an amino acid in the protein-building sense. It carries an -SO3H sulfonic acid group instead of the -COOH carboxylic acid group, and it never gets stitched into a polypeptide chain. That structural quirk is part of why its work looks so different from what cysteine or methionine do.

So what does it actually do. In the liver, it conjugates bile acids, helping decide whether bile salts ship out as taurocholate or as glycocholate. That choice shapes fat digestion and the gut microbiome. Across most tissues, it stabilizes membranes through an osmotic and calcium-binding effect. Inside mitochondria, it modifies transfer RNAs through a derivative called 5-taurinomethyluridine, and that modification is what allows clean translation of mitochondrially encoded electron transport chain subunits. In neutrophils, it forms taurine chloramine on the way to dampening the cytokine burst that runs alongside infection. And in the central nervous system, it acts as a weak GABA receptor agonist with glycine receptor co-agonism, which is the mild calm people sometimes notice with larger doses. Different lanes. Same molecule doing all the driving.

The mitochondrial angle is the one most users underestimate. Specific mitochondrial tRNAs are modified by a taurine-derived chemical group (5-taurinomethyluridine), and that modification is what allows them to translate the right codons in mitochondrial messenger RNAs. Without it, translation of mitochondrially encoded Complex I and Complex IV subunits goes sideways, and oxidative phosphorylation drops. MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes) is partly a disease of this exact modification failing. That is the mechanistic anchor for why taurine has been tested in heart failure, in athletic recovery, and in the aging context. Mitochondria are downstream of taurine status, not the other way around.

Cardiac evidence is the strongest part of the clinical picture. Taurine has been licensed in Japan as a treatment for congestive heart failure for decades. The original work from Azuma and colleagues in the 1980s reported meaningful improvements in NYHA functional class at 3 to 6 grams per day. Modern echocardiographic work has confirmed effects on left ventricular function in chronic heart failure populations. The mechanism is concrete. Taurine stabilizes calcium handling in cardiomyocytes through the sarcoplasmic reticulum, modulates the beta-adrenergic response, and protects against catecholamine-driven calcium overload. The Schaffer lab has spent decades mapping this. Outside Japan, mainstream cardiology has not picked it up, but the published trial data is real and Japanese clinicians use it routinely.

Blood pressure shows a quieter but consistent effect. Meta-analyses of randomized trials report drops in the 3 to 7 mmHg range for systolic in hypertensive adults at doses around 1.5 to 3 grams per day, with the effect tied to improved endothelial function, mild vascular relaxation, and reduced sympathetic tone. Insulin sensitivity shifts modestly in the same direction. Athletic recovery trials have shown reduced muscle damage markers and lower delayed-onset soreness at 1 to 3 grams, though the acute performance effect on its own is small.

Typical supplement doses run from 500 mg up to 6 grams per day, taken with or without food. The 1 gram per day used in the Singh group's human pilot sits on the low end. Heart failure protocols stack at 3 to 6 grams, divided. Athletic users target 1 to 3 grams pre-training. The half-life is short, around an hour or two, so dividing larger doses across the day fits the biology better than a single hit. Energy drinks typically deliver around 1 gram per can, mostly riding alongside caffeine and B vitamins; the dose is real, the format is mixed with stimulants by design.

Two comparisons matter. Beta-alanine and taurine share the same transporter into cells (TauT, also called SLC6A6). Chronic high-dose beta-alanine supplementation lowers intracellular taurine in animal data, which is the reason lifters who run heavy beta-alanine protocols sometimes pair them. The clinical relevance in humans is genuinely unclear, but the transporter competition is real. Magnesium glycinate is the other natural comparison, because both compounds support cardiac calcium handling and both have mild calming effects through different receptor systems. The two stack cleanly with no known interaction.

Cats are the classic teaching case. They cannot synthesize taurine and develop dilated cardiomyopathy and retinal degeneration without dietary intake, which is why commercial cat food is taurine-fortified. Humans synthesize some but variably, and stress, illness, alcohol use, vegetarian diets (taurine is essentially absent in plants), and certain anticonvulsants all push endogenous production below demand.

A few practical cautions. Taurine can mildly amplify the calming effect of GABAergic drugs (benzodiazepines, certain anticonvulsants, alcohol). Lithium-treated patients should know that taurine may shift renal lithium handling marginally. Long-term combination with bile acid sequestrants (cholestyramine, colesevelam) is not ideal because of the conjugation pathway. None of this is medical advice. If you take prescription medication, are pregnant, or manage a chronic condition, run higher doses past a clinician, especially the heart failure range.

The practical view. Taurine sits in an unusual position. Decades-old cardiac evidence used routinely in Japan. A clean mitochondrial mechanism that explains why aging research keeps pointing back at it. Real but modest effects on blood pressure, glucose handling, and athletic recovery. A safety record that is essentially boring. The 2023 Science paper does not turn it into a longevity miracle. What it does is anchor the case for treating taurine as one of the better-evidenced supplements for cellular bioenergetics, particularly if cardiac function or mitochondrial efficiency is the angle you care about.